Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Amazon
AMZN
|
+$781M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$428M |
| 3 |
Meta Platforms (Facebook)
META
|
+$405M |
| 4 |
Uber
UBER
|
+$379M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$259M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.8B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$634M |
| 3 |
Apple
AAPL
|
+$537M |
| 4 |
Mastercard
MA
|
+$467M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$437M |
Sector Composition
| 1 | Technology | 16.3% |
| 2 | Financials | 12.05% |
| 3 | Consumer Discretionary | 11.61% |
| 4 | Healthcare | 11.53% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
ATAI Life Sciences
ATAI
$992M
| $4.95M | ﹤0.01% |
648,575
-74,334
| -10% | -$567K |
|
2002
A.O. Smith
AOS
$10.2B
| $4.94M | ﹤0.01% |
57,544
-251,428
| -81% | -$21.6M |
|
2003
Takeda Pharmaceutical
TAK
$47.7B
| $4.93M | ﹤0.01% |
362,018
-37,960
| -9% | -$517K |
|
|
FST
2004
DELISTED
FAST Acquisition Corp.
FST
| $4.92M | ﹤0.01% |
484,396
+465,319
| +2,439% | +$4.73M |
|
|
PRDS
2005
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $4.91M | ﹤0.01% |
300,000
-6,767
| -2% | -$111K |
|
|
FRON
2006
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
| $4.91M | ﹤0.01% |
500,000
-2
| -0% | -$20 |
|
2007
CenterPoint Energy
CNP
$25B
| $4.9M | ﹤0.01% |
175,392
-293,289
| -63% | -$8.19M |
|
2008
Liberty Latin America Class C
LILAK
$1.53B
| $4.88M | ﹤0.01% |
+428,243
| New | +$4.88M |
|
|
BRMK
2009
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $4.88M | ﹤0.01% |
517,715
+388,517
| +301% | +$3.66M |
|
2010
Cheniere Energy
CQP
$25.2B
| $4.88M | ﹤0.01% |
115,491
+12,448
| +12% | +$526K |
|
2011
Envoy Medical
COCH
$27.8M
| $4.88M | ﹤0.01% |
500,007
+7
| +0% | +$68 |
|
2012
Lindsay Corp
LNN
$1.52B
| $4.86M | ﹤0.01% |
31,990
+18,274
| +133% | +$2.78M |
|
|
OHAA
2013
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
| $4.86M | ﹤0.01% |
+492,080
| New | +$4.86M |
|
|
VEEA
2014
Veea Inc. Common Stock
VEEA
$27.4M
| $4.85M | ﹤0.01% |
500,743
-51
| -0% | -$494 |
|
|
TIOA
2015
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
| $4.84M | ﹤0.01% |
+500,300
| New | +$4.84M |
|
2016
ProShares UltraPro Short S&P 500
SPXU
$505M
| $4.84M | ﹤0.01% |
+77,779
| New | +$4.84M |
|
|
STSA
2017
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $4.84M | ﹤0.01% |
1,075,620
+3,006
| +0.3% | +$13.5K |
|
2018
Zillow
ZG
$20.4B
| $4.84M | ﹤0.01% |
77,770
-10,405
| -12% | -$647K |
|
|
POND
2019
DELISTED
Angel Pond Holdings Corporation
POND
| $4.84M | ﹤0.01% |
+500,386
| New | +$4.84M |
|
2020
Steelcase
SCS
$1.93B
| $4.82M | ﹤0.01% |
411,239
+139,811
| +52% | +$1.64M |
|
2021
Valaris
VAL
$3.71B
| $4.81M | ﹤0.01% |
133,481
-21,177
| -14% | -$762K |
|
2022
Cognyte Software
CGNT
$622M
| $4.8M | ﹤0.01% |
306,273
-125
| -0% | -$1.96K |
|
|
HCCC
2023
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
| $4.79M | ﹤0.01% |
485,536
-968
| -0.2% | -$9.55K |
|
2024
Certara
CERT
$1.81B
| $4.78M | ﹤0.01% |
168,337
+147,768
| +718% | +$4.2M |
|
|
VRTV
2025
DELISTED
VERITIV CORPORATION
VRTV
| $4.78M | ﹤0.01% |
38,957
+34,291
| +735% | +$4.2M |
|